Delivery Order SPE2DB20D2104-SPE2DB25FMQAQ

Award Date 5/2/25
Potential Completion Date 5/5/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,077,688 tablets of the medication dapagliflozin 10 mg. The $5,948.05 firm fixed-price contract has an ultimate completion date of April 30, 2025 and is not a set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
This is a $1,224.71 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,840 units of dapagliflozin 10 mg tablets. The contract has a period of performance through September 18, 2024 and was awarded on September 17, 2022. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities, veterans' hospitals, and other...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,376.58 contract is for the supply of 4,567,951,816 units of the diabetes medication Dapagliflozin 10 mg tablets. The award has an ultimate completion date of April 18, 2025 and is not a set-aside contract, indicating open competition. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,406.23 firm fixed-price contract is for the supply of 4,565,693,581 units of the pharmaceutical product dapagliflozin 10 mg tablets. The award has an ultimate completion date of September 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) worth up to $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,566,026,518 units of the pharmaceutical product dapagliflozin 10 mg tablets. The contract has a ceiling value of $4,650.24 and an ultimate completion date of October 7, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,000 units of the prescription medication Dapagliflozin 10 mg tablets, a treatment for diabetes. The contract has a firm fixed price of $2,313.10 and a performance period ending on April 23, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,396.00 delivery order is for the supply of 4,564,766,189 units of the prescription medication Dapagliflozin 10 mg tablets. The contract has a firm-fixed price and is not set aside for any specific business category. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,274.86 firm fixed-price contract is for the delivery of 4,565,614,775 Dapagliflozin 10 mg tablets. The contract has an ultimate completion date of August 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 4,565,825,260 units of dapagliflozin 5 mg tablets. The contract has a ceiling value of $1,588.40 and a completion date of September 17, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will supply these essential prescription medications to support various federal...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The order is for 4,565,296,475 units of the pharmaceutical product Dapagliflozin 10 mg Tablet in 30-count packages. The fixed-price contract has a ceiling value of $29,210.27 and a completion date of July 31, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMQAQ
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,961.68, is for the delivery of 4,568,120 units of the prescription medication dapagliflozin 10 mg tablets. The contract is a firm fixed-price, non-set-aside award with a completion date of May 5, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military and other government healthcare programs through December 2026.

Generated 8/3/25, 1:35 AM